Health problems rise before early-onset Alzheimer’s, but not familiar risk factors #Alzheimersdisease #Finland #health

Health problems rise before early-onset Alzheimer’s, but not familiar risk factors #Alzheimersdisease #Finland #health
New clinical trial
A Randomized Controlled Trial of Peer Support for Family Caregivers of Black Older Adults Living With Dementia (Pair 2 Care)
New clinical trial
An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan
🧠How does #tauprotein cause #tauopathies like #AlzheimersDisease? Through #Mitochondria! Find out more in our Mitoblog interview with Dr. Lu on his @cp-neuron.bsky.social paper:
#mitoscientists #UMDF #AD #neurodegeneration #neurodegenerativediseases #mitoneuro
New clinical trial
A Single-center, Single-arm, Prospective, Open-label, Pilot Clinical Trial to Evaluate the Safety and Efficacy of the Focused Ultrasound Stimulator System (NMS-01) for Transient Blood-Brain Barrier (BBB) Opening in Patients...
Targeting the #peripheral #immune system for treatment of #AlzheimersDisease
Emissa Almasarani, Morten H. Fog, Thomas Vorup-Jensen, Kristian Juul-Madsen @aarhusuniint.bsky.social
New clinical trial
Safety and Feasibility Study of ATTN201 Centromedian Nucleus of the Thalamus Focused Ultrasound Stimulation for Enhanced Glymphatic Clearance in Amyloid Positive Patients With Mild Cognitive Impairment
New clinical trial
A Postmarketing Study to Confirm Treatment Benefit and Fulfill Conditions Associated With Market Authorization in Canada for LEQEMBI (Lecanemab) Administered in Adult Patients With a Clinical Diagnosis of Mild Cognitive Imp...
Beneficial vs. pathogenic #microglia functions across aging, #MultipleSclerosis, and #AlzheimersDisease
Jonathan K. Monteiro & Véronique E. Miron @uoftpress.bsky.social
New clinical trial
A Prospective, Single-Center, Randomized, Subject-Assessor Double-Blind, Sham-Controlled, Exploratory Clinical Trial to Evaluate the Pre- and Post-Treatment Changes of HeLaXON, a Low-Dose Radiation Therapy Device, in Patien...
New clinical trial
DayBreak: A Pilot Randomised Trial of a Grief Support App for Adults Experiencing Bereavement
#TrendingNow | Disease-associated #microglia are associated with #AlzheimersDisease, #ALS and #aging. This Essay discusses the dynamics, origins and therapeutic potential of these microglia in neurodegeneration 🧪 #ICYMI #NeuroSky plos.io/49mmzcm
I’m still kicking, and recorded a great session with RIVR Media’s “Living Our Best with Memory Loss” podcast! #alzheimers #dementia #imstillme #alzheimersdisease #alzheimersawareness sredfern.substack.com/p/my-13-mont...
💊A review of dextromethorphan and bupropion (Auvelity™) for the treatment of agitation in Alzheimer’s disease
Tampi et al.
www.drugsincontext.com/a-review-of-...
#Geriatrics #Psychiatry #Agitation #AlzheimersDisease #Auvelity
@me.pharmsky.app @moderation.medsky.network
We’re thrilled to share that we're expanding our licensing agreement with Quanterix to advance next generation Alzheimer's disease biomarker research.
🔗Read the full announcement: alzpath.bio/alzpath-and-...
New clinical trial
Microsurgical Modification of Cervical Lymphatic Pathways in Alzheimer's Disease: A Pilot Study
New clinical trial
Negotiation Training to Optimize Caregiver Communication in Alzheimer's Disease
New clinical trial
Evaluating the Effects of Restoring Lymphatic Drainage in Alzheimer's Disease: The LymphDAD Pilot Study
When I was growing up, “weed” was a social thing. I smoked it & baked it into brownies. Now it’s an important part of treating symptoms of many illnesses, including agitation in dementia patients. #dementia #alzheimers #alzheimersdisease #alzheimersawareness sredfern.substack.com/p/calming-th...
#TrendingNow | Neurons are thought to be the main source of pathogenic amyloid beta in #AlzheimersDisease. This study identified oligodendrocytes as significant contributors to amyloid beta production, suggesting they could potentially be targeted therapeutically #ICYMI #NeuroSky 🧪 plos.io/3zYNU56